SERIALIZATION & BEYOND...
Thought leadership articles, expert advice, compliance updates and more on serialization, aggregation and business intelligence.
Falsified Medicines Directive Compliance: A Quick Overview of Requirements for Wholesalers, Distributors and Logistics Partners
Each passing day brings the pharmaceutical industry closer to the inevitable deadline of February 9, 2019 and the enforcement of serialization, track and trace and reporting requirements imposed by the European Falsified Medicines Directive (FMD) 2011/62/EU to many stakeholders at different levels of the pharmaceutical supply chain.
The Falsified Medicines Directive (FMD) 2011/62/EU
To fight against this scourge, the European Union (EU) has put in place directive 2011/62/EU or Falsified Medicines Directive with which pharmaceutical manufacturers (whether MAH or CMO) as well as their supply chain partners will have to comply by early 2019.